Pediatrix Medical (MD) Capital Expenditures (2009 - 2026)

Pediatrix Medical has disclosed Capital Expenditures across 18 years of filings, most recently posting $6.2 million for Q1 2026.

• In Q1 2026, Capital Expenditures rose 88.28% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at $4.4 million (up 818.95% YoY), while the FY2025 annual figure was $1.5 million, up 5.07% from the prior year.
• Capital Expenditures rose to $6.2 million in Q1 2026, from -$11.7 million in the prior quarter.
• Over the last five years, Capital Expenditures for MD reached as high as $9.2 million in Q3 2023 and fell as low as -$17.2 million in Q4 2024.
• The 5-year median for Capital Expenditures is $6.6 million (2022), against an average of $4.2 million.
• Annual changes were most pronounced in 2022 — Capital Expenditures soared 133.82% — and 2024, when it tumbled 289.98%.
• A 5-year view of Capital Expenditures shows it stood at $9.1 million in 2022, then retreated by 0.15% to $9.0 million in 2023, then plunged by 289.98% to -$17.2 million in 2024, then surged by 31.91% to -$11.7 million in 2025, then soared by 153.39% to $6.2 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $6.2 million, -$11.7 million, and $5.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.